Answers are grounded in this paper and cite their sources.
To determine whether levels and/or ratios of MS disease-relevant immune cells in the CSF and plasma are associated with NfL levels, and how they are impacted by disease-modifying treatments (DMTs).
No takes yet. Share an insight, caveat, or question.
Arsenault et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: